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Roseoloviruses are ubiquitous worldwide. Its infection in children is very common causing a disease 
named as Roseola infantum. It appears that most of the children are still being suffered by the same 
disease without any proper treatment all over the world. And, the situation becomes worst when these 
latent viruses reactivated in future to develop disease complications and cancer in human. The Present 
review is an attempt to describe Roseoloviruses causing diseases including cancer in human in the light 
of recent researches done so far in the past. 
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Introduction 
Roseoloviruses is a linear, double stranded DNA virus belonging to the order Herpesvirales, 
family Herpesviridae and the subfamily Betaherpesvirinae. These are of two types named 
HHV-6 & HHV-7. HHV-6 has further been categorized as HHV-6A & HHV-6B. These 
viruses were first isolated either from patients suffering from lymphoproliferative diseases 
and AIDS (HHV-6) or from CD4+ T cells taken from peripheral blood lymphocytes (HHV-
7) [Salahuddin et al. 1986 and Frenkel et al. 1990] [29, 10]. Roseoloviruses cause a rash 
developing disease in human known as Roseola infantum whose entire disease cycle is 
completed within 3 to 6 days. Once after an infection, the Roseoloviruses remain latent for 
lifelong. Virus may cause cancer (Masroor et al., 2020) [23] and tumor suppressor genes may 
be reactivated (Saha et al., 2020) [28]. Studies have shown that some of these hidden viruses if 
reactivated in future develop severe complications in human [Anni et al. 2015, Henri et al. 
2015 and Vanessa and Louis 2017] [4, 11, 33]. The present study discusses the Roseoloviruses 
causing diseases, complications and cancer in human.  
 
Clinical presentation 
Roseola infantum is a mild viral infection of children most commonly involving 6 months to 
3 years. Almost all children have been infected with the virus during their childhood. The 
disease is also known as the Exanthema subitum or “sixth disease” because this is sixth in 
series of rash developing disease which also lasted in about six days [Taspinar et al. 2013] 
[32]. 
The disease is characterized by a sudden onset of rise in temperature followed by the rose 
coloured rashes that dissipitates after a few days. Usually, these rose coloured rashes are 
formed on neck, trunk and thighs first and then spread on legs and face. The infections are 
contagious during the fever phase especially by saliva but not spread via rashes. The salivary 
glands are the natural reservoir of these Roseoloviruses [Agut 2011 and Jessica et al. 2020] 
[3, 14]. No treatment is generally required except to keep the fever down and drink plenty of 
fluids. Although, rare, febrile seizures may occur due to high fever. Similar, symptoms are 
associated with HHV-7 virus too. If these viruses reactivated later in life due to some 
unavoidable circumstances such as immunocompromisation or with the use of 
immunosuppressants they may cause several ailments, diseases and even cancer in future 
[Stone et al. 2014 and Henri et al. 2015] [31, 11]. 
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Oncology of the virus  
Roseoloviruses have got their own distinguishing ability to 
be integrated in human chromosomes. They are covalently 
integrated into subtelomeric region of human chromosomes 
in about 1% of the general population [Henri et al. 2015] 
[11]. Further, the process of gametogenesis and the fusion of 
gametes transfer the same integration to the next generation 
increasing the risk of developing three times angina in 
humans [Anni et al. 2015 and Vanessa and Louis 2017] [4, 
33]. Some of other ailments and diseases including cancer 
caused by these viruses are briefly summarized as under: 
1. HHV-6 has been found to be associated with the patients 
suffering from multiple sclerosis, a neuroinflammatory 
disease, causing demyelination in brain [Ablashi et al. 
2000, Hernan et al. 2001, Delbue et al. 2012 and 
Pietilainen and Virtanen 2014] [1, 12, 7, 25]. Further, it has 
been detected in some kind of brain tumors [Kofman et 
al. 2011] [17]. The human p53 protein functions as a 
tumor suppressor. The persons not having this protein 
experience a higher incidence of cancer, a phenomenon 
known as “Li-Fraumeni syndrome”. Deregulation of p53 
protein factor is associated with cancer. For example, 
two of the HHV-6 viral gene products named U14 and 
ORF-1 proteins bind with p53 protein and inactivating it 
to cause cancer [Kofman et al. 2011] [17]. 
2. HHV-6 has also been implicated as a cofactor in chronic 
fatigue syndrome (CFS). CFS is a debilitating disease of 
unknown etiology showing neurological, immunological 
and metabolic findings. Scientists have shown an 
association between CFS and HHV-6. But, largely, it 
remains found to be unproven [Buchwald et al. 1992, 
Wagner et al. 1996, Ablashi et al. 2000, Nicolson et al. 
2003 and Komaroff 2006] [5, 34, 1, 24, 18]. 
3. Similarly, the cells infected with the roseoloviruses are 
comprehensively being engaged in complete replication 
cycle to cause disturbed apoptosis and necrosis 
developing cancer and death of cells respectively [Henri 
et al. 2015] [11]. 
4. In addition, HHV-6 develops fibromyalgia in AIDS 
patient [Pietilainen and Virtanen 2014] [25]. 
5. Researchers have shown that T-cells are highly 
infectable by HHV-6 virus. [Lusso et al. 1995 and 
Laurie and Philip 2014] [20, 19]. 
6. Further, Roseoloviruses has been found to be associated 
with the pathogenesis of a common neurological 
disorder as epilepsy. HHV-6 has some connection with 
temporal lobe epilepsy [Fotheringham et al. 2007] [9]. 
Further, it has also been reported that the virus enters the 
brain via olefactory pathways. But, it still requires more 
researches to prove the link [Santa et al. 2020] [30]. These 
viruses have also been found to be linked with 
Alzheimers [Readhead et al. 2018 and Denner et al. 
2019] [26, 8]. 
7. Roseoloviruses can also cause encephalitis and brain 
dysfunction in both immunocompetent and 
immunocompromised individuals [Joseph et al. 2017] 
[15]. 
8. HHV-6 has also been found as an important factor for 
female infertility [Roberto et al. 2016] [27]. 
9. Hoshimoto thyroiditis disease has been found to be 
linked with HHV-6. This is a kind of thyroid ailment 
where increased lymphocytes are found [Caselli et al. 
2012] [6]. 
10. Finally, there are reports that Roseoloviruses have 
frequently been reactivated in transplant recipients 
[Joshua and Danielle 2014 and Denner et al. 2019] [8]. 
 
Prevention of infections  
To date, no any specific prevention measure is available for 
Roseoloviruses. We can only hope a good hygiene can only 
keep us away from the virus. The disease and the disease 
complications are still being treated symptomatically. 
Similarly, there is no vaccine available for the prevention of 
infection. Further studies are still required to establish 
various casualties of same viral infections to explore the 
prevention and treatment options [Joshua and Danielle 
2014]. 
 
Treatment of the disease 
Roseola infantum is a common paediatric disease caused by 
the Roseoloviruses. Though, the primary infections of the 
Roseoloviruses do not require any treatment, other 
complications arising after reactivation of the viruses are 
being treated with the help of an antiviral ganciclovir 
[Imataki and Uemura 2015] [13]. It can also reduce the risk of 
reactivation in high risk transplant patients [Joshua and 
Danielle 2014]. Currently, an effective vaccine is utmost 
needed for the prevention and treatment of Roseoloviruses 
and Roseola infantum respectively. 
 
Conclusion  
Roseoloviruses cause a disease in children known as 
Roseola infantum. Almost, all children of the world have 
been infected with the same virus at least once in their 
lifetime with lifelong latencies in the same individuals. 
Further, the extra quality being acquired by this virus to be 
integrated with the human chromosomes enlarges the risk of 
reactivation causing complications developing several 
diseases including cancer in future course of time. 
Unfortunately, no vaccines have so far been discovered for 
the prevention and treatment of Roseoloviruses. However, 
some antivirals have been tried to control the disease 
complications. Last but not the least, as cancer often takes 
years, even decades to develop after a person gets an 
infection, there is nothing more to worry about it except to 
be alert. Similarly, since there is no way to know which 
people who have cancer causing pathogens will develop 
cancer, it arises from his bad luck. [Masroor et al. 2018, 
2019 and 2020] [21, 22, 23]. 
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